Transient iron overload with bleomycin detectable iron in the plasma of patients with adult respiratory distress syndrome.

BACKGROUND--A retrospective study was conducted to evaluate iron status in plasma samples collected from five patients with the adult respiratory distress syndrome (ARDS) who had bleomycin detectable iron in at least one sample. Ten patients with ARDS with no evidence of bleomycin detectable iron and 10 healthy individuals served as controls. METHODS--Evidence of iron overload was established by measuring the percentage saturation of plasma transferrin. In each case the bleomycin assay for redox active, chelatable iron was used to measure plasma levels of non-transferrin bound iron in the low micromolar range; assays for total plasma iron and transferrin were performed to establish a diagnosis of transient iron overload. The effect of this on the ability of transferrin to act as a plasma antioxidant was assessed using two different assay systems. RESULTS--The five patients with evidence of transient iron overload (mortality 4/5) represented 33% of the total population of patients with ARDS (mortality 5/10) managed by the unit during the study period. All had low molecular mass iron detectable in their plasma and had clinical and biochemical evidence of multiorgan system failure as well as liver impairment. Compared with the ARDS and normal control populations, transferrin and albumin levels were low and the former failed to act as a plasma antioxidant in preventing free radical mediated damage to detector molecules. CONCLUSIONS--Patients with ARDS are thought to be under severe oxidative stress from their disease and from treatment with high inspired oxygen concentrations. A subgroup of patients with ARDS has been identified who displayed evidence of transient iron overload as a result of which their plasma iron binding antioxidant protection was greatly compromised. This finding must be considered a serious additional risk factor for oxidative stress.

[1]  T. Evans,et al.  Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins. , 1994, The Journal of laboratory and clinical medicine.

[2]  B. Halliwell,et al.  Bleomycin‐detectable iron in the plasma of premature and full‐term neonates , 1992, FEBS letters.

[3]  C. Cross,et al.  Free radicals, antioxidants, and human disease: where are we now? , 1992, The Journal of laboratory and clinical medicine.

[4]  T. Evans,et al.  Management of adult respiratory distress syndrome , 1992, The Lancet.

[5]  B. Ames,et al.  Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. , 1990, The Journal of laboratory and clinical medicine.

[6]  M. Couturier,et al.  Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome , 1990, Critical care medicine.

[7]  B. Halliwell,et al.  1 Iron toxicity and oxygen radicals , 1989 .

[8]  G. Mufti,et al.  Bleomycin‐detectable iron in serum from leukaemic patients before and after chemotherapy Therapeutic implications for treatment with oxidant‐generating drugs , 1988, FEBS letters.

[9]  J F Murray,et al.  An expanded definition of the adult respiratory distress syndrome. , 1988, The American review of respiratory disease.

[10]  C. C. Baker,et al.  THE YALE JOURNAL OF BIOLOGY AND MEDICINE 59 (1986), 575-597 The Adult Respiratory Distress Syndrome , 1985 .

[11]  R. Simon,et al.  OXIDANT ACTIVITY IN EXPIRED BREATH OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROME , 1986, The Lancet.

[12]  H. Wallenburg,et al.  LOW-DOSE ASPIRIN PREVENTS PREGNANCY-INDUCED HYPERTENSION AND PRE-ECLAMPSIA IN ANGIOTENSIN-SENSITIVE PRIMIGRAVIDAE , 1986, The Lancet.

[13]  E. Draper,et al.  Prognosis in Acute Organ‐System Failure , 1985, Annals of surgery.

[14]  L. Hudson,et al.  Causes of Mortality in Patients with the Adult Respiratory Distress Syndrome , 1985, The American review of respiratory disease.

[15]  B. Halliwell,et al.  Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. , 1985, Clinical science.

[16]  B. Halliwell,et al.  Inhibition of lipid peroxidation by the iron-binding protein lactoferrin. , 1981, The Biochemical journal.

[17]  B. Halliwell,et al.  Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA. , 1981, The Biochemical journal.

[18]  T. Petty,et al.  The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management. , 1971, Chest.

[19]  J. Gutteridge,et al.  Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. , 1993, Biochimica et biophysica acta.

[20]  J. Lindeman,et al.  Limited protection against iron-induced lipid peroxidation by cord blood plasma. , 1992, Free radical research communications.

[21]  B. Halliwell,et al.  Iron toxicity and oxygen radicals. , 1989, Bailliere's clinical haematology.

[22]  J. Gutteridge,et al.  Iron complexes and their reactivity in the bleomycin assay for radical-promoting loosely-bound iron. , 1986, Free radical research communications.